Company leader
Andrew Mignatti
Co-Founder and CEO
Careviso
Andrew Mignatti is co-founder and chief executive of Careviso. Its software, seeQer, checks eligibility, estimates what a patient will owe, and clears prior authorization before a lab or specialty visit.
Business Development at LabCorp
He holds a bachelor of arts from St. Edward's University in Austin, Texas. He began at Allergy Testing Laboratory and became regional director of sales before LabCorp acquired the company. As director of business development at LabCorp he led acquisitions in his division. He then held executive roles at RedPath Integrated Pathology, now Interpace Diagnostics, and was chief executive of Perthera, where he raised $10 million and doubled sales.
He founded careviso in 2017. Since then the company has put an automated system in front of more than 60 clients and laboratories and has moved past diagnostic prior authorization into other specialties.